纵横研报
Ticker Detail

600351.SHG

¥6.72+2.75% 亚宝药业 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Yabao Pharmaceutical Group Co Ltd
医疗健康 · 专科与仿制药

Yabao Pharmaceutical Group Co., Ltd engages in the research and development, production, and sale of pharmaceutical products in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, analgesics, psychotropic drugs, women's health products, patches, and general health products. The company was founded in 1978 and is based in Beijing, China.

MARKET 市值 4.33B CNY PE 13.6x Fwd 30.1x 52W ¥5.6 – ¥8.68 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY -6.9% ROE 10.5% 营业利润率 23.7% 净利润率 14.5%
ANALYST 股息率 5.75%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制